NCT02066090

Brief Summary

This research is planned to build a basis about the effect of acupuncture on serum metabolic parameters in pre-menopausal obese women with economic evaluation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable obesity

Timeline
Completed

Started Mar 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 14, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 19, 2014

Completed
10 days until next milestone

Study Start

First participant enrolled

March 1, 2014

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2016

Completed
Last Updated

November 17, 2017

Status Verified

November 1, 2017

Enrollment Period

1.9 years

First QC Date

February 14, 2014

Last Update Submit

November 14, 2017

Conditions

Keywords

acupunctureobesitymetabolomics

Outcome Measures

Primary Outcomes (1)

  • change in serum metabolic profile

    before treatment at week1 (baseline) and after treatment at week6 (endpoint)

Secondary Outcomes (12)

  • change in body weight

    baseline, 1, 2, 3, 4, 5, and 6 weeks

  • change in body fat mass

    baseline, 1, 2, 3, 4, 5, and 6 weeks

  • change in muscle mass

    baseline, 1, 2, 3, 4, 5, and 6 weeks

  • change in waist circumference

    baseline, 1, 2, 3, 4, 5, and 6 weeks

  • change in hip circumference

    baseline, 1, 2, 3, 4, 5, and 6 weeks

  • +7 more secondary outcomes

Other Outcomes (2)

  • change in Measure Yourself Medical Outcome Profile (MYMOP)

    baseline, 1, 2, 3, 4, 5, and 6 weeks

  • change in EuroQol-5 Dimension (EQ-5D)

    baseline and 6 weeks

Study Arms (2)

Real acupuncture

EXPERIMENTAL

manual acupuncture + electroacupuncture, twice a week, for 6 weeks

Device: Real acupuncture

Sham acupuncture

SHAM COMPARATOR

sham acupuncture + placebo acupuncture without electrical stimulation, twice a week, for 6 weeks

Device: Sham acupuncture

Interventions

manual acupuncture (bilateral LI4, LI11, SP6, ST25, ST28, ST36) + electroacupuncture (middle CV6, CV12), twice a week, for 6 weeks common approaches for the treatment of obesity used by doctors of Korean medicine in Korea today

Real acupuncture

sham acupuncture (bilateral LI4, LI11, SP6, ST25, ST28, ST36) + placebo acupuncture without electrical stimulation (middle CV6, CV12), twice a week, for 6 weeks sham acupuncture (0.25mm diameter x 40mm length, stainless steel, Acuprime, UK) as control for manual acupuncture (0.25mm diameter x 40mm length, stainless steel, Dongbangacupuncture Inc., Korea) placebo acupuncture without electrical stimulation as control for electroacupuncture (0.25mm diameter x 90mm length, stainless steel, Dongbangacupuncture Inc., Korea)

Sham acupuncture

Eligibility Criteria

Age19 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • volunteers through announcements and advertisements
  • premenopausal adult women (19 years of age or more)
  • clinical diagnosis of obesity (Body mass index: 25 kg/m2 or more)

You may not qualify if:

  • previously or currently having endocrine disease such as hypothyroidism or Cushing's syndrome, heart disease, lung disease, diabetes, malignant tumor, cholelithiasis, severe kidney impairment, severe liver impairment, anorexia nervosa or hyperorexia
  • experience of taking medicines which might affect body weight and the concentration of serum metabolic parameters such as anorectic, laxative, oral steroid, thyroid hormone, amphetamine, cyproheptadine, phenothiazine, or medicines affecting absorption, metabolism, and excretion in the past 3 months
  • experience of taking beta-blocker or diuretic for the treatment of hypertension in the past 3 months
  • surgical treatment for the treatment of obesity
  • currently or might be pregnant or breast-feeding
  • experience of taking other experimental medicines in the past month
  • weight loss of 10% or more of previous body weight in the past 6 months
  • who stopped smoking in the past 3 months or who have irregular smoking habit
  • pacemaker
  • currently receiving any treatment for obesity
  • other inadequate subjects assessed by the study investigators

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kyung Hee University Korean Medicine Hospital at Gangdong

Seoul, 134-727, South Korea

Location

Related Publications (2)

  • Kim KW, Shin WC, Choi MS, Cho JH, Park HJ, Yoo HH, Song MY. Effects of acupuncture on anthropometric and serum metabolic parameters in premenopausal overweight and obese women: a randomized, patient- and assessor-blind, sham-controlled clinical trial. Acupunct Med. 2021 Feb;39(1):30-40. doi: 10.1177/0964528420912259. Epub 2020 Apr 17.

  • Kim KW, Yoo HH, Cho JH, Yang YC, Kim JI, Kim SY, Park JY, Park HJ, Song MY. Effects of acupuncture on serum metabolic parameters in premenopausal obese women: study protocol for a randomized controlled trial. Trials. 2015 Aug 4;16:327. doi: 10.1186/s13063-015-0867-y.

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mi-Yeon Song, Ph.D.

    Department of Rehabilitation Medicine of Korean Medicine, Kyung Hee University Gangdong Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, K.M.D., Ph.D.

Study Record Dates

First Submitted

February 14, 2014

First Posted

February 19, 2014

Study Start

March 1, 2014

Primary Completion

February 1, 2016

Study Completion

February 1, 2016

Last Updated

November 17, 2017

Record last verified: 2017-11

Locations